Noncompliance With Directly Observed Therapy for Tuberculosis
Authors:
- David L. CohnDCDavid L. Cohn
- Cornelis A. RietmeijerCRCornelis A. Rietmeijer
- Franklyn N. JudsonFJFranklyn N. Judson
- Randall R. RevesRRRandall R. Reves
- John A. SbarbaroJSJohn A. Sbarbaro
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- 165-PC11/12 Drug resistant tuberculosis in New York City, 1991–1994Tubercle and Lung Disease, 1995
- Tuberculosis in New York City — Turning the TideNew England Journal of Medicine, 1995
- The Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in TuberculosisNew England Journal of Medicine, 1994
- Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programmeTubercle and Lung Disease, 1993
- Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and RifampinNew England Journal of Medicine, 1993
- Resurgent Tuberculosis in New York City: Human Immunodeficiency Virus, Homelessness, and the Decline of Tuberculosis Control ProgramsAmerican Review of Respiratory Disease, 1991
- Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosisRespiratory Medicine, 1991
- A 62-Dose, 6-Month Therapy for Pulmonary and Extrapulmonary TuberculosisAnnals of Internal Medicine, 1990
- Patient Compliance: The Most Serious Remaining Problem in the Control of Tuberculosis in the United StatesChest, 1979
- DEFINITIONS OF ATTRIBUTABLE RISKAmerican Journal of Epidemiology, 1973